시장조사 보고서 : 세계의 과민성 방광 치료 시장예측 2021년-2026년

■ 영문 제목 : Global Overactive Bladder Treatment Market Growth (Status and Outlook) 2021-2026
	■ 상품코드 : LPI-2201K02444 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 87 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료장치

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1명 열람용)	USD3,660 ⇒환산￦5,124,000	견적의뢰/주문/질문
Multi User (5명 열람용)	USD5,490 ⇒환산￦7,686,000	견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)	USD7,320 ⇒환산￦10,248,000	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

본 조사보고서는 과민성 방광 치료의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (의약품, 디바이스)와 용도별 시장규모 (특발성 과민성 방광, 신경성 과민성 방광) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 과민성 방광 치료 시장 점유율
- 지역별 과민성 방광 치료 시장규모
- 주요지역의 종류별 시장규모 (의약품, 디바이스)
- 주요지역의 용도별 시장규모 (특발성 과민성 방광, 신경성 과민성 방광)
- 미주의 과민성 방광 치료 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 과민성 방광 치료 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 과민성 방광 치료 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 과민성 방광 치료 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 과민성 방광 치료 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
Allergan, Astellas Pharma, Pfizer, Johnson & Johnson, Medtronic, KYORIN Pharmaceutical
- 조사의 결과/결론

■ 보고서 개요

According to this latest study, the 2021 growth of Overactive Bladder Treatment will have significant change from previous year. By the most conservative estimates of global Overactive Bladder Treatment market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 4901 million in 2020. Over the next five years the Overactive Bladder Treatment market will register a 3.1% CAGR in terms of revenue, the global market size will reach US$ 5540.2 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Overactive Bladder Treatment market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Drugs
Device
Drug segment dominated the market with share about 98.5%.

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Idiopathic Overactive Bladder
Neurogenic Overactive Bladder
The idiopathic overactive bladder holds an important share in terms of applications, and accounts for 80% of the market share.

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Allergan
Astellas Pharma
Pfizer
Johnson & Johnson
Medtronic
KYORIN Pharmaceutical

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Overactive Bladder Treatment Market Size 2016-2026
2.1.2 Overactive Bladder Treatment Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Overactive Bladder Treatment Segment by Type
2.2.1 Drugs
2.2.2 Drugs
2.3 Overactive Bladder Treatment Market Size by Type
2.3.1 Global Overactive Bladder Treatment Market Size CAGR by Type
2.3.2 Global Overactive Bladder Treatment Market Size Market Share by Type (2016-2021)
2.4 Overactive Bladder Treatment Segment by Application
2.4.1 Idiopathic Overactive Bladder
2.4.2 Neurogenic Overactive Bladder
2.5 Overactive Bladder Treatment Market Size by Application
2.5.1 Global Overactive Bladder Treatment Market Size CAGR by Application
2.5.2 Global Overactive Bladder Treatment Market Size Market Share by Application (2016-2021)

3 Overactive Bladder Treatment Market Size by Players
3.1 Overactive Bladder Treatment Market Size Market Share by Players
3.1.1 Global Overactive Bladder Treatment Revenue by Players (2019-2021E)
3.1.2 Global Overactive Bladder Treatment Revenue Market Share by Players (2019-2021E)
3.2 Global Overactive Bladder Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Overactive Bladder Treatment by Regions
4.1 Overactive Bladder Treatment Market Size by Regions (2016-2021)
4.2 Americas Overactive Bladder Treatment Market Size Growth (2016-2021)
4.3 APAC Overactive Bladder Treatment Market Size Growth (2016-2021)
4.4 Europe Overactive Bladder Treatment Market Size Growth (2016-2021)
4.5 Middle East & Africa Overactive Bladder Treatment Market Size Growth (2016-2021)

5 Americas
5.1 Americas Overactive Bladder Treatment Market Size by Country (2016-2021)
5.2 Americas Overactive Bladder Treatment Market Size by Type (2016-2021)
5.3 Americas Overactive Bladder Treatment Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Overactive Bladder Treatment Market Size by Region (2016-2021)
6.2 APAC Overactive Bladder Treatment Market Size by Type (2016-2021)
6.3 APAC Overactive Bladder Treatment Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Overactive Bladder Treatment by Country (2016-2021)
7.2 Europe Overactive Bladder Treatment Market Size by Type (2016-2021)
7.3 Europe Overactive Bladder Treatment Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Overactive Bladder Treatment by Region (2016-2021)
8.2 Middle East & Africa Overactive Bladder Treatment Market Size by Type (2016-2021)
8.3 Middle East & Africa Overactive Bladder Treatment Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Overactive Bladder Treatment Market Forecast
10.1 Global Overactive Bladder Treatment Forecast by Regions (2021-2026)
10.1.1 Global Overactive Bladder Treatment Forecast by Regions (2021-2026)
10.1.2 Americas Overactive Bladder Treatment Forecast
10.1.3 APAC Overactive Bladder Treatment Forecast
10.1.4 Europe Overactive Bladder Treatment Forecast
10.1.5 Middle East & Africa Overactive Bladder Treatment Forecast
10.2 Americas Overactive Bladder Treatment Forecast by Countries (2021-2026)
10.2.1 United States Overactive Bladder Treatment Market Forecast
10.2.2 Canada Overactive Bladder Treatment Market Forecast
10.2.3 Mexico Overactive Bladder Treatment Market Forecast
10.2.4 Brazil Overactive Bladder Treatment Market Forecast
10.3 APAC Overactive Bladder Treatment Forecast by Region (2021-2026)
10.3.1 China Overactive Bladder Treatment Market Forecast
10.3.2 Japan Overactive Bladder Treatment Market Forecast
10.3.3 Korea Overactive Bladder Treatment Market Forecast
10.3.4 Southeast Asia Overactive Bladder Treatment Market Forecast
10.3.5 India Overactive Bladder Treatment Market Forecast
10.3.6 Australia Overactive Bladder Treatment Market Forecast
10.4 Europe Overactive Bladder Treatment Forecast by Country (2021-2026)
10.4.1 Germany Overactive Bladder Treatment Market Forecast
10.4.2 France Overactive Bladder Treatment Market Forecast
10.4.3 UK Overactive Bladder Treatment Market Forecast
10.4.4 Italy Overactive Bladder Treatment Market Forecast
10.4.5 Russia Overactive Bladder Treatment Market Forecast
10.5 Middle East & Africa Overactive Bladder Treatment Forecast by Region (2021-2026)
10.5.1 Egypt Overactive Bladder Treatment Market Forecast
10.5.2 South Africa Overactive Bladder Treatment Market Forecast
10.5.3 Israel Overactive Bladder Treatment Market Forecast
10.5.4 Turkey Overactive Bladder Treatment Market Forecast
10.5.5 GCC Countries Overactive Bladder Treatment Market Forecast
10.6 Global Overactive Bladder Treatment Forecast by Type (2021-2026)
10.7 Global Overactive Bladder Treatment Forecast by Application (2021-2026)

11 Key Players Analysis
11.1 Allergan
11.1.1 Allergan Company Information
11.1.2 Allergan Overactive Bladder Treatment Product Offered
11.1.3 Allergan Overactive Bladder Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Allergan Main Business Overview
11.1.5 Allergan Latest Developments
11.2 Astellas Pharma
11.2.1 Astellas Pharma Company Information
11.2.2 Astellas Pharma Overactive Bladder Treatment Product Offered
11.2.3 Astellas Pharma Overactive Bladder Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Astellas Pharma Main Business Overview
11.2.5 Astellas Pharma Latest Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer Overactive Bladder Treatment Product Offered
11.3.3 Pfizer Overactive Bladder Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Pfizer Main Business Overview
11.3.5 Pfizer Latest Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Information
11.4.2 Johnson & Johnson Overactive Bladder Treatment Product Offered
11.4.3 Johnson & Johnson Overactive Bladder Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 Johnson & Johnson Main Business Overview
11.4.5 Johnson & Johnson Latest Developments
11.5 Medtronic
11.5.1 Medtronic Company Information
11.5.2 Medtronic Overactive Bladder Treatment Product Offered
11.5.3 Medtronic Overactive Bladder Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Medtronic Main Business Overview
11.5.5 Medtronic Latest Developments
11.6 KYORIN Pharmaceutical
11.6.1 KYORIN Pharmaceutical Company Information
11.6.2 KYORIN Pharmaceutical Overactive Bladder Treatment Product Offered
11.6.3 KYORIN Pharmaceutical Overactive Bladder Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 KYORIN Pharmaceutical Main Business Overview
11.6.5 KYORIN Pharmaceutical Latest Developments

12 Research Findings and Conclusion

List of Tables
Table 1. Overactive Bladder Treatment Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Drugs
Table 3. Major Players of Device
Table 4. Overactive Bladder Treatment Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 5. Global Overactive Bladder Treatment Market Size by Type (2016-2021) & ($ Millions)
Table 6. Global Overactive Bladder Treatment Market Size Market Share by Type (2016-2021)
Table 7. Overactive Bladder Treatment Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 8. Global Overactive Bladder Treatment Market Size by Application (2016-2021) & ($ Millions)
Table 9. Global Overactive Bladder Treatment Market Size Market Share by Application (2016-2021)
Table 10. Global Overactive Bladder Treatment Revenue by Players (2019-2021E) & ($ Millions)
Table 11. Global Overactive Bladder Treatment Revenue Market Share by Players (2019-2021E)
Table 12. Overactive Bladder Treatment Key Players Head office and Products Offered
Table 13. Overactive Bladder Treatment Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Overactive Bladder Treatment Market Size by Regions 2016-2021 & ($ Millions)
Table 17. Global Overactive Bladder Treatment Market Size Market Share by Regions 2016-2021
Table 18. Americas Overactive Bladder Treatment Market Size by Country (2016-2021) & ($ Millions)
Table 19. Americas Overactive Bladder Treatment Market Size Market Share by Country (2016-2021)
Table 20. Americas Overactive Bladder Treatment Market Size by Type (2016-2021) & ($ Millions)
Table 21. Americas Overactive Bladder Treatment Market Size Market Share by Type (2016-2021)
Table 22. Americas Overactive Bladder Treatment Market Size by Application (2016-2021) & ($ Millions)
Table 23. Americas Overactive Bladder Treatment Market Size Market Share by Application (2016-2021)
Table 24. APAC Overactive Bladder Treatment Market Size by Region (2016-2021) & ($ Millions)
Table 25. APAC Overactive Bladder Treatment Market Size Market Share by Region (2016-2021)
Table 26. APAC Overactive Bladder Treatment Market Size by Type (2016-2021) & ($ Millions)
Table 27. APAC Overactive Bladder Treatment Market Size Market Share by Type (2016-2021)
Table 28. APAC Overactive Bladder Treatment Market Size by Application (2016-2021) & ($ Millions)
Table 29. APAC Overactive Bladder Treatment Market Size Market Share by Application (2016-2021)
Table 30. Europe Overactive Bladder Treatment Market Size by Country (2016-2021) & ($ Millions)
Table 31. Europe Overactive Bladder Treatment Market Size Market Share by Country (2016-2021)
Table 32. Europe Overactive Bladder Treatment Market Size by Type (2016-2021) & ($ Millions)
Table 33. Europe Overactive Bladder Treatment Market Size Market Share by Type (2016-2021)
Table 34. Europe Overactive Bladder Treatment Market Size by Application (2016-2021) & ($ Millions)
Table 35. Europe Overactive Bladder Treatment Market Size Market Share by Application (2016-2021)
Table 36. Middle East & Africa Overactive Bladder Treatment Market Size by Region (2016-2021) & ($ Millions)
Table 37. Middle East & Africa Overactive Bladder Treatment Market Size Market Share by Region (2016-2021)
Table 38. Middle East & Africa Overactive Bladder Treatment Market Size by Type (2016-2021) & ($ Millions)
Table 39. Middle East & Africa Overactive Bladder Treatment Market Size Market Share by Type (2016-2021)
Table 40. Middle East & Africa Overactive Bladder Treatment Market Size by Application (2016-2021) & ($ Millions)
Table 41. Middle East & Africa Overactive Bladder Treatment Market Size Market Share by Application (2016-2021)
Table 42. Key and Potential Regions of Overactive Bladder Treatment
Table 43. Key Application and Potential Industries of Overactive Bladder Treatment
Table 44. Key Challenges of Overactive Bladder Treatment
Table 45. Key Trends of Overactive Bladder Treatment
Table 46. Global Overactive Bladder Treatment Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 47. Global Overactive Bladder Treatment Market Size Market Share Forecast by Regions (2021-2026)
Table 48. Global Overactive Bladder Treatment Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 49. Global Overactive Bladder Treatment Market Size Market Share Forecast by Type (2021-2026)
Table 50. Global Overactive Bladder Treatment Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 51. Global Overactive Bladder Treatment Market Size Market Share Forecast by Application (2021-2026)
Table 52. Allergan Details, Company Type, Overactive Bladder Treatment Area Served and Its Competitors
Table 53. Allergan Overactive Bladder Treatment Product Offered
Table 54. Allergan Overactive Bladder Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 55. Allergan Main Business
Table 56. Allergan Latest Developments
Table 57. Astellas Pharma Details, Company Type, Overactive Bladder Treatment Area Served and Its Competitors
Table 58. Astellas Pharma Overactive Bladder Treatment Product Offered
Table 59. Astellas Pharma Main Business
Table 60. Astellas Pharma Overactive Bladder Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 61. Astellas Pharma Latest Developments
Table 62. Pfizer Details, Company Type, Overactive Bladder Treatment Area Served and Its Competitors
Table 63. Pfizer Overactive Bladder Treatment Product Offered
Table 64. Pfizer Main Business
Table 65. Pfizer Overactive Bladder Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 66. Pfizer Latest Developments
Table 67. Johnson & Johnson Details, Company Type, Overactive Bladder Treatment Area Served and Its Competitors
Table 68. Johnson & Johnson Overactive Bladder Treatment Product Offered
Table 69. Johnson & Johnson Main Business
Table 70. Johnson & Johnson Overactive Bladder Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 71. Johnson & Johnson Latest Developments
Table 72. Medtronic Details, Company Type, Overactive Bladder Treatment Area Served and Its Competitors
Table 73. Medtronic Overactive Bladder Treatment Product Offered
Table 74. Medtronic Main Business
Table 75. Medtronic Overactive Bladder Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 76. Medtronic Latest Developments
Table 77. KYORIN Pharmaceutical Details, Company Type, Overactive Bladder Treatment Area Served and Its Competitors
Table 78. KYORIN Pharmaceutical Overactive Bladder Treatment Product Offered
Table 79. KYORIN Pharmaceutical Main Business
Table 80. KYORIN Pharmaceutical Overactive Bladder Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 81. KYORIN Pharmaceutical Latest Developments
List of Figures
Figure 1. Overactive Bladder Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Overactive Bladder Treatment Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Overactive Bladder Treatment Market Size Market Share by Type in 2020
Figure 7. Overactive Bladder Treatment in Idiopathic Overactive Bladder
Figure 8. Global Overactive Bladder Treatment Market: Idiopathic Overactive Bladder (2016-2021) & ($ Millions)
Figure 9. Overactive Bladder Treatment in Neurogenic Overactive Bladder
Figure 10. Global Overactive Bladder Treatment Market: Neurogenic Overactive Bladder (2016-2021) & ($ Millions)
Figure 11. Global Overactive Bladder Treatment Market Size Market Share by Application in 2020
Figure 12. Global Overactive Bladder Treatment Revenue Market Share by Player in 2020
Figure 13. Global Overactive Bladder Treatment Market Size Market Share by Regions (2016-2021)
Figure 14. Americas Overactive Bladder Treatment Market Size 2016-2021 ($ Millions)
Figure 15. APAC Overactive Bladder Treatment Market Size 2016-2021 ($ Millions)
Figure 16. Europe Overactive Bladder Treatment Market Size 2016-2021 ($ Millions)
Figure 17. Middle East & Africa Overactive Bladder Treatment Market Size 2016-2021 ($ Millions)
Figure 18. Americas Overactive Bladder Treatment Market Size Market Share by Country in 2020
Figure 19. Americas Overactive Bladder Treatment Market Size Market Share by Type in 2020
Figure 20. Americas Overactive Bladder Treatment Market Size Market Share by Application in 2020
Figure 21. United States Overactive Bladder Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 22. Canada Overactive Bladder Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 23. Mexico Overactive Bladder Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 24. APAC Overactive Bladder Treatment Market Size Market Share by Regions in 2020
Figure 25. APAC Overactive Bladder Treatment Market Size Market Share by Type in 2020
Figure 26. APAC Overactive Bladder Treatment Market Size Market Share by Application in 2020
Figure 27. China Overactive Bladder Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 28. Japan Overactive Bladder Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 29. Korea Overactive Bladder Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 30. Southeast Asia Overactive Bladder Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 31. India Overactive Bladder Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 32. Australia Overactive Bladder Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 33. Europe Overactive Bladder Treatment Market Size Market Share by Country in 2020
Figure 34. Europe Overactive Bladder Treatment Market Size Market Share by Type in 2020
Figure 35. Europe Overactive Bladder Treatment Market Size Market Share by Application in 2020
Figure 36. Germany Overactive Bladder Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 37. France Overactive Bladder Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 38. UK Overactive Bladder Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 39. Italy Overactive Bladder Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 40. Russia Overactive Bladder Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 41. Middle East & Africa Overactive Bladder Treatment Market Size Market Share by Region in 2020
Figure 42. Middle East & Africa Overactive Bladder Treatment Market Size Market Share by Type in 2020
Figure 43. Middle East & Africa Overactive Bladder Treatment Market Size Market Share by Application in 2020
Figure 44. Egypt Overactive Bladder Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 45. South Africa Overactive Bladder Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 46. Israel Overactive Bladder Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 47. Turkey Overactive Bladder Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 48. GCC Country Overactive Bladder Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 49. Americas Overactive Bladder Treatment Market Size 2021-2026 ($ Millions)
Figure 50. APAC Overactive Bladder Treatment Market Size 2021-2026 ($ Millions)
Figure 51. Europe Overactive Bladder Treatment Market Size 2021-2026 ($ Millions)
Figure 52. Middle East & Africa Overactive Bladder Treatment Market Size 2021-2026 ($ Millions)
Figure 53. United States Overactive Bladder Treatment Market Size 2021-2026 ($ Millions)
Figure 54. Canada Overactive Bladder Treatment Market Size 2021-2026 ($ Millions)
Figure 55. Mexico Overactive Bladder Treatment Market Size 2021-2026 ($ Millions)
Figure 56. Brazil Overactive Bladder Treatment Market Size 2021-2026 ($ Millions)
Figure 57. China Overactive Bladder Treatment Market Size 2021-2026 ($ Millions)
Figure 58. Japan Overactive Bladder Treatment Market Size 2021-2026 ($ Millions)
Figure 59. Korea Overactive Bladder Treatment Market Size 2021-2026 ($ Millions)
Figure 60. Southeast Asia Overactive Bladder Treatment Market Size 2021-2026 ($ Millions)
Figure 61. India Overactive Bladder Treatment Market Size 2021-2026 ($ Millions)
Figure 62. Australia Overactive Bladder Treatment Market Size 2021-2026 ($ Millions)
Figure 63. Germany Overactive Bladder Treatment Market Size 2021-2026 ($ Millions)
Figure 64. France Overactive Bladder Treatment Market Size 2021-2026 ($ Millions)
Figure 65. UK Overactive Bladder Treatment Market Size 2021-2026 ($ Millions)
Figure 66. Italy Overactive Bladder Treatment Market Size 2021-2026 ($ Millions)
Figure 67. Russia Overactive Bladder Treatment Market Size 2021-2026 ($ Millions)
Figure 68. Spain Overactive Bladder Treatment Market Size 2021-2026 ($ Millions)
Figure 69. Egypt Overactive Bladder Treatment Market Size 2021-2026 ($ Millions)
Figure 70. South Africa Overactive Bladder Treatment Market Size 2021-2026 ($ Millions)
Figure 71. Israel Overactive Bladder Treatment Market Size 2021-2026 ($ Millions)
Figure 72. Turkey Overactive Bladder Treatment Market Size 2021-2026 ($ Millions)
Figure 73. GCC Country Overactive Bladder Treatment Market Size 2021-2026 ($ Millions)

※본 조사보고서 [세계의 과민성 방광 치료 시장예측 2021년-2026년] (코드 : LPI-2201K02444) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 과민성 방광 치료 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 조사자료도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 과민성 방광 (OAB) 치료제 시장예측 2021년-2026년
LPI-2201K02127 / LP Information / 2021년 12월 / 본 조사보고서는 과민성 방광 (OAB) 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2021 growth of Overactive Bladder (OAB) Therapeutics will have significant change from previous year. By the most conservative estimates of global Overactive Bladder (OAB) Therapeutics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 3125...

세계의 초음파 방광 스캐너 시장예측 2021년-2026년
LPI-2201K02667 / LP Information / 2021년 12월 / 본 조사보고서는 초음파 방광 스캐너의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Ultrasonic Bladder Scanner will have significant change from previous year. By the most conservative estimates of global Ultrasonic Bladder Scanner market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in...

세계의 전이성 암 치료 시장예측 2021년-2026년
LPI-2201K02228 / LP Information / 2021년 12월 / 본 조사보고서는 전이성 암 치료의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Metastatic Cancer Treatment will have significant change from previous year. By the most conservative estimates of global Metastatic Cancer Treatment market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 49140 million in...

세계의 패혈증 치료 시장예측 2021년-2026년
LPI-2201K02174 / LP Information / 2021년 12월 / 본 조사보고서는 패혈증 치료의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Sepsis Treatment will have significant change from previous year. By the most conservative estimates of global Sepsis Treatment market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 3072.3 million in 2020. Over...